Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 24 results for "kiran mazumdar shaw"

Biocon's adjusted Q4 net profit up; company issues bonus shares
Money Today

Biocon to address French regulator concerns in a quarter: Mazu...

Kiran Mazumdar Shaw, chairman and managing director of Biocon says that India's largest Biopharma company will take remedial measures at its drug product facility within a quarter and ask the French medical regulator to inspect its facility again to get ... Business Standard, 1 week ago

13 images for kiran mazumdar shaw

Money Control, 1 week ago
Money Control, 2 weeks ago
Money Today, 2 months ago
Livemint.com, 5 months ago
Business Standard, 5 months ago
Financial Express, 5 months ago
DealStreetAsia, 5 months ago
Money Control, 4 months ago
DNA, 5 months ago
BusinessInsider.co.id, 6 months ago
Money Control

People are very concerned about the complexity of GST: Kiran Mazumdar Shaw

In an interview to CNBC-TV18#39;s Shereen Bhan, Kiran Mazumdar-Shaw CMD, Biocon spoke about the goods and services tax (GST) and its impacts on her company and Indian economy.
 Money Control2 weeks ago Disappointed at multi-tiered approach of GST: Mazumdar-Shaw  DNA3 weeks ago Countdown to GST: Find out how India Inc views its impacts  Money Control1 month ago
Sify

GST impact: Pharma sector supply chain coping well after rollout

Time is needed to prepare for commercial launch of the new products: Biocon CMD Kiran Mazumdar Shaw
 Business Standard2 weeks ago GST impact: Supply chain in pharma sector seems to be coping post rollout  Business Standard2 weeks ago Supply chain in pharma sector seems to be coping post-GST: Biocon  Sify2 weeks ago

ODAC’s approval takes us one step closer to USFDA nod for trastuzumab: Biocon’s CMD

The United States Foods and Drug Administration (USFDA) Oncologic Drugs Advisory Committee (ODAC) has recommended an approval of a biosimilar trastuzumab in the US. Trastuzumab is Biocon and Mylan#39;s biosimilar which is a biosimilar version of Herceptin ...
 Money Control6 days ago

Shekhar Gupta’s ThePrint raises funding from Narayan Murthy, Ratan Tata, Nandan Nilekani and others

Shekhar Gupta’s multimedia digital news platform, ThePrint has raised an undisclosed amount of funding from Infosys co-founders N.R Narayana Murthy and Nandan Nilekani, industrialist Ratan Tata, Uday Kotak Family, Biocon founder Kiran Mazumdar Shaw, ...
 Medianama1 week ago

Bangalore taps tech to fix unruly gridlock

In Bangalore, tech giants and startups typically spend their days fiercely battling each other for customers. Now they are turning their attention to a common enemy: the city’s infernal traffic congestion. Cross-town commutes that can take hours has ...
 The Financial Chronicle1 week ago

Will try ask for re-inspection at the earliest, says Biocon

There appears to be a setback for Biocon as its biosimilars program hits a roadblock in Europe -- the drug products unit inspection done in March has not received the GMP certificate by the French regulator. In an interview to CNBC-TV18, Kiran Mazumdar Shaw, ...
 Money Control1 week ago

Opposition to GST from some people who don't want to pay tax, says FM

Finance Minister Arun Jaitley on Saturday said there is no reason for unease among traders about the rollout of the Goods and Sales Tax (GST), saying a lot of opposition has come from people who do not want to pay any tax. "Unease over the transition is ...
 Deccan Herald2 weeks ago

Infosys appoints D Sundaram as independent director

Countrys second largest software services firm Infosys today announced the appointment of D Sundaram as an independent director with effect from July 14. The appointment is based on the recommendations of the Nomination and Remuneration Committee of the ...
 Deccan Herald2 weeks ago

GST Council lowers rates for 66 items

The GST Council on Sunday lowered rates for many consumer items, school bags and cinema tickets below Rs 100 but left the much awaited revision on hybrid car to be decided after considering comments from states on a discussion paper on the issue. The Council ...
 Deccan Herald1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less